NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 319 filers reported holding NOVOCURE LTD in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $477,000 | +31.0% | 6,284 | +42.9% | 0.04% | +63.0% |
| Q1 2022 | $364,000 | +0.8% | 4,399 | -8.5% | 0.03% | -27.0% |
| Q4 2021 | $361,000 | -72.2% | 4,808 | -17.8% | 0.04% | -70.6% |
| Q2 2021 | $1,297,000 | +197.5% | 5,846 | +77.2% | 0.13% | +306.5% |
| Q1 2021 | $436,000 | -21.9% | 3,299 | -34.2% | 0.03% | -67.7% |
| Q3 2020 | $558,000 | -56.4% | 5,013 | -75.2% | 0.10% | +28.0% |
| Q2 2019 | $1,280,000 | – | 20,245 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
| MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
| Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
| Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
| Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
| Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
| Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |